Bath & Body Works Stock Plummets to New 52-Week Low at $22.38

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 22.38 as of November 7, 2025. This marks a significant decline for the small-cap company, which operates within the footwear industry. Over the past year, Bath & Body Works has experienced a substantial drop in its stock price, with a performance decline of 49.79%, contrasting sharply with the S&P 500's gain of 12.65%.
The company's financial metrics reveal a challenging landscape. With a market capitalization of USD 6,299 million, Bath & Body Works has a price-to-earnings (P/E) ratio of 7.00, indicating a low valuation relative to earnings. However, the company is grappling with a negative book value and a return on equity that is notably concerning. Additionally, net sales have decreased at an annual rate of 8.28%, while operating profit has shown minimal growth.

The stock's performance has been characterized by consistent underperformance against the S&P 500 over the last three years, raising questions about its long-term viability in the market. As Bath & Body Works navigates these financial challenges, its recent price movement reflects ongoing pressures within the industry.